MedImmune founder Wayne T. Hockmeyer, Ph.D. is retiring as president of MedImmune Ventures, Inc. Dr. Hockmeyer has also stepped down as the company’s chairman upon AstraZeneca’s completion of its tender offer to acquire all outstanding shares of MedImmune common stock. Dr. Hockmeyer commented, “I am honored to have been a part of building one of the most successful biotechnology companies in the world. The last 19 years at MedImmune have been exciting, professionally stimula...